Navigating the Unpredictability of Factor VII Deficiency – EHC
EHC – European Haemophilia Consortium shared a post on LinkedIn:
“Extremely Rare Bleeding Disorder of the Month: Factor VII (FVII) Deficiency
In FVII Deficiency, an extremely rare inherited bleeding disorder, low or missing levels of this protein mean the body struggles to kick-start clot formation, leading to prolonged or unexpected bleeding.
What can this look like?
- Nosebleeds and easy bruising
- Prolonged bleeding after injury or surgery
- Heavy menstrual bleeding
- Bleeding into muscles or joints
- In severe cases, gastrointestinal bleeding or intracranial haemorrhage
One thing to know: symptoms vary widely from person to person, and bleeding severity doesn’t always match Factor VII levels, making this a highly unpredictable condition to live with and diagnose.
Because FVII Deficiency is so rare and so variable, diagnosis is often delayed or missed. Awareness, specialised care, and individualised treatment plans are key to reducing bleeding risk and supporting long-term health.
Want to learn more?
Visit the ERIN Focus Area on the EHC Community website for webinars, podcasts, and publications on extremely rare bleeding disorders.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 17:15Cedric Hermans: Identifying and Diagnosing Hemophilia Carriers and Affected Females
-
Oct 12, 2026, 17:01Bianca Rocca: Evaluating Factor XI Inhibition Lessons from LIBREXIA-ACS
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution